Hester Biosciences Stock Price Analysis and Quick Research Report. Is Hester Biosciences an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Hester Biosciences. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Hester Biosciences has a PE ratio of 57.6516292023184 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Hester Biosciences has ROA of 5.813% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Hester Biosciences has a Current ratio of 1.9155.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Hester Biosciences has a ROE of 9.7705%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Hester Biosciences has a Debt to Equity ratio of 0.3075 which means that the company has low proportion of debt in its capital.

• Sales growth: Hester Biosciences has reported revenue growth of 0.4597% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Hester Biosciences for the current financial year is 17.7836113186207%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Hester Biosciences is Rs 7 and the yield is 0.3294%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Hester Biosciences is Rs 36.7327. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Hester Biosciences in Ticker for free. Also, one can get the intrinsic value of Hester Biosciences by using Valuation Calculators, which are available with a Finology ONE subscription. 

Hester Biosciences FAQs

Q1. What is Hester Biosciences share price today?
Ans: The current share price of Hester Biosciences is Rs 2117.7.

Q2. What is the market capitalisation of Hester Biosciences?
Ans: Hester Biosciences has a market capitalisation of Rs 1801.49880105 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Hester Biosciences?
Ans: The PE ratio of Hester Biosciences is 57.6516292023184 and the P/B ratio of Hester Biosciences is 5.19276392013584, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Hester Biosciences share?
Ans: The 52-week high share price of Hester Biosciences is Rs 2786.1, and the 52-week low share price of Hester Biosciences is Rs 1242.95.

Q5. Does Hester Biosciences pay dividends?
Ans: Currently, Hester Biosciences pays dividends. Dividend yield of Hester Biosciences is around 0.3294%.

Q6. What are the face value and book value of Hester Biosciences shares?
Ans: The face value of Hester Biosciences shares is Rs 10, while the book value per share of Hester Biosciences is around Rs 407.8175. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Hester Biosciences?
Ans: Hester Biosciences has a total debt of Rs 104.267 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Hester Biosciences?
Ans: The ROE of Hester Biosciences is 9.7705% and ROCE of Hester Biosciences is 10.5947%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Hester Biosciences a good buy for the long term?
Ans: The Hester Biosciences long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Hester Biosciences undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Hester Biosciences appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Hester Biosciences’s financials?
Ans: You can review Hester Biosciences’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.